You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

 

Online download statistics by month:

Online download statistics by month: September 2022 to March 2026

AbstractFullPdf
Sep 2022332353114
Oct 2022482505246
Nov 2022254258119
Dec 202220921170
Jan 2023277285111
Feb 202327728098
Mar 202326526781
Apr 202329430094
May 202316716953
Jun 202313914053
Jul 202315415573
Aug 202316817260
Sep 202315415469
Oct 202316717082
Nov 202316216475
Dec 202314714976
Jan 202413313573
Feb 202416016075
Mar 2024163165107
Apr 2024236238118
May 202417517799
Jun 202418018293
Jul 202415015180
Aug 202411611571
Sep 202415515980
Oct 202413213472
Nov 202415916076
Dec 202422723493
Jan 202518919083
Feb 202524724767
Mar 202519119390
Apr 2025266270129
May 202521621888
Jun 202522722888
Jul 2025110
Sep 2025100
Mar 2026110
Total697370903056